FDA to Reconsider Restrictions on Diabetes Drug

Published June 3, 2013

FDA to Reconsider Restrictions on Diabetes Drug
But critics, like Dr. Steven Nissen, the well-known Cleveland Clinic cardiologist who was the first to sound a public alarm about the drug, say it is far too dangerous to use in diabetes treatment. He said an analysis of more than 50 studies linked …
Read more on New York Times (blog)

Legalize It and They Will Analyze It
Beau Kilmer, a co-director of the nonprofit RAND Corporation's Drug Policy Research Center, says that when he and his colleagues first tried to determine the likely consequences of marijuana legalization, "one of our takeaways was that a lot of the …
Read more on Chronicle of Higher Education (subscription)

New cancer drug shows promise for treating advanced melanoma
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer. … the …
Read more on EurekAlert (press release)